Major depressive disorder in DSM-5: Implications for clinical practice and research of changes from DSM-IV

Depression and Anxiety

Volumn 31, Issue 6, 2014, Pages 459-471

  Uher, Rudolf ^a,b   Payne, Jennifer L ^c   Pavlova, Barbara ^a   Perlis, Roy H ^d  

^a DALHOUSIE UNIVERSITY   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Assessment; Classification; Diagnosis; Major depressive disorder; Persistent depressive disorder; Psychopathology

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE;

AGITATION; ANHEDONIA; BEREAVEMENT; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CATALEPSY; CATATONIA; CLINICAL PRACTICE; CLINICAL RESEARCH; DEFENSE MECHANISM; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DISTRACTIBILITY; DISTRESS SYNDROME; DSM-5; DSM-IV; DYSTHYMIA; ECHOLALIA; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENERALIZED ANXIETY DISORDER; GESTURE; HOPELESSNESS; HUMAN; HYPOMANIA; IRRITABILITY; LONG TERM CARE; MAJOR DEPRESSION; MENTAL DISEASE; MIXED MANIA AND DEPRESSION; MOOD DISORDER; MUTISM; NEUROSIS; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMOTOR RETARDATION; PSYCHOSIS; RESTLESSNESS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDAL IDEATION; CLASSIFICATION; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;

DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS;

EID: 84902486234     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22217     Document Type: Review

References (78)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Association; 2013.
2. Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013;381:1371-1379.
3. Lichtenstein P, Yip BH, Bjork C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009;373:234-239.
4. Lee SH, Ripke S, Neale BM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 2013;45:984-994.
5. Rasic D, Hajek T, Alda M, Uher R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. Schizophr Bull 2013; doi:10.1093/schbul/sbt114.
6. Berk M, Berk L, Moss K, Dodd S, Malhi GS. Diagnosing bipolar disorder: how can we do it better? Med J Aust 2006;184:459-462.
7. Etain B, Lajnef M, Bellivier F, et al. Clinical expression of bipolar disorder type I as a function of age and polarity at onset: convergent findings in samples from France and the United States. J Clin Psychiatry 2012;73:e561-e566.
8. Lish JD, Me-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. JAffectDisord 1994;31:281-294.
9. Abramson LY, Metalsky GI, Alloy LB. Hopelesness depression: a theory-based subtype of depression. Psychological Rev 1989;96:358-372.
10. Beck AT, Steer RA, Beck JS, Newman CF. Hopelessness, depression, suicidal ideation, and clinical diagnosis of depression. Suicide Life Threat Behav 1993;23:139-145.
11. Greene SM. The relationship between depression and hopelessness. Implications for current theories of depression. Br J Psychiatry 1989;154:650-659.
12. Joiner TE, Jr., Steer RA, Abramson LY, Alloy LB, Metalsky GI, Schmidt NB. Hopelessness depression as a distinct dimension of depressive symptoms among clinical and non-clinical samples. Behav Res Ther 2001;39:523-536.
13. Marsiglia FF, Kulis S, Garcia PH, Bermudez-Parsai M. Hopelessness, family stress, and depression among Mexican-heritage mothers in the southwest. Health Soc Work 2011;36:7-18.
14. Uher R, Farmer A, Maier W, et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 2008;38:289-300.
15. Karam EG, Tabet CC, Alam D, et al. Bereavement related and non-bereavement related depressions: a comparative field study. J Affect Disord 2009;112:102-110.
16. Kendler KS, Myers J, Zisook S. Does bereavement-related major depression differ from major depression associated with other stressful life events? Am J Psychiatry 2008;165:1449-1455.
17. Kessing LV, Bukh JD, Bock C, Vinberg M, Gether U. Does bereavement-related first episode depression differ from other kinds of first depressions? Soc Psychiatry Psychiatr Epidemiol 2010;45:801-808.
18. Mojtabai R. Bereavement-related depressive episodes: characteristics, 3-year course, and implications for the DSM-5. Arch Gen Psychiatry 2011;68:920-928.
19. Wakefield JC, Schmitz MF, First MB, Horwitz AV. Extending the bereavement exclusion for major depression to other losses: evidence from the National Comorbidity Survey. Arch Gen Psychiatry 2007;64:433-440.
20. Zisook S, Kendler KS. Is bereavement-related depression different than non-bereavement-related depression? Psychol Med 2007;37:779-794.
21. Corruble E, Falissard B, Gorwood P. Is DSM-IV bereavement exclusion for major depression relevant to treatment response? A case-control, prospective study. J Clin Psychiatry 2011;72:898-902.
22. Wakefield JC, Schmitz MF. Recurrence of depression after bereavement-related depression: evidence for the validity of DSM-IV bereavement exclusion from the Epidemiologic Catchment Area Study. J Nerv Ment Dis 2012;200:480-485.
23. Gilman SE, Breslau J, Trinh NH, Fava M, Murphy JM, Smoller JW. Bereavement and the diagnosis of major depressive episode in the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2012;73:208-215.
24. Wakefield J, First M. Fallacious reasoning in the argument to eliminate the major depression bereavement exclusion in DSM-5. World Psychiatry 2012;11:204-205.
25. Placidi GP, Oquendo MA, Malone KM, Brodsky B, Ellis SP, Mann JJ. Anxiety in major depression: relationship to suicide attempts. Am J Psychiatry 2000;157:1614-1618.
26. Bjerkeset O, Romundstad P, Gunnell D. Gender differences in the association of mixed anxiety and depression with suicide. Br J Psychiatry 2008;192:474-475.
27. *D report. Am J Psychiatry 2008;165:342-351.
28. Uher R, Dernovsek MZ, Mors O, et al. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. J Affect Disord 2011;132:112-120.
29. Angst J, Azorin JM, Bowden CL, et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry 2011;68:791-798.
30. Perlis RH, Uher R, Ostacher M, et al. Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. ArchGen Psychiatry 2011;68:351-360.
31. Weygand W. Ü ber die Mischzustände des manisch-depressiven Irreseins (On the Mixed States of Manic-Depressive Insanit). Verlag von J. F. Lehmann, Munich, Germany 1899.
32. Kraepelin E. Manic Depressive Insanity and Paranoia. E. & S. Livingstone, Edinburgh, 1921.
33. Koukopoulos A, Sani G. DSM-5criteria for depression with mixed features: a farewell to mixed depression. Acta Psychiatr Scand 2013; doi: 10.1111/acps.12140. [Epub ahead of print]
34. Salvatore P, Baldessarini RJ, Centorrino F, et al. Weygandt's On the Mixed States of Manic-Depressive Insanity: a translation and commentary on its significance in the evolution of the concept of bipolar disorder. Harv Rev Psychiatry 2002;10:255-275.
35. Parker G, Roussos J, Eyers K, Wilhelm K, Mitchell P, Hadzi-Pavlovic D. How distinct is 'distinct quality' of mood? Psychol Med 1997;27:445-453.
36. Di Florio A, Forty L, Gordon-Smith K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry 2013;70:168-175.
37. Yonkers KA, Gotman N, Smith MV, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology 2011;22:848-854.
38. Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006;295:499-507.
39. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000;157:179-184.
40. Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007;164:1817-1824.
41. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005;106:1071-1083.
42. Banti S, Mauri M, Oppo A, et al. From the third month of pregnancy to 1 year postpartum. Prevalence, incidence, recurrence, and new onset of depression. Results from the perinatal depression-research & screening unit study. Compr Psychiatry 2011;52:343-351.
43. Altemus M, Neeb CC, Davis A, Occhiogrosso M, Nguyen T, Bleiberg KL. Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder. J Clin Psychiatry 2012;73:e1485-e1491.
44. Munk-Olsen T, Laursen TM, Meltzer-Brody S, Mortensen PB, Jones I. Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Arch Gen Psychiatry 2012;69:428-434.
45. Payne JL, Roy PS, Murphy-Eberenz K, et al. Reproductive cycleassociated mood symptoms in women with major depression and bipolar disorder. J Affect Disord 2007;99:221-229.
46. Forty L, Jones L, Macgregor S, et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry 2006;163:1549-1553.
47. Payne JL, MacKinnon DF, Mondimore FM, et al. Familial aggregation of postpartum mood symptoms in bipolar disorder pedigrees. Bipolar Disord 2008;10:38-44.
48. Uher R. Book review: The Conceptual Evolution of DSM-5. J Autism Developmental Disord 2012;42:143-145.
49. Uher R, Rutter M. Basing psychiatric classification on scientific foundation: problems and prospects. Int Rev Psychiatry 2012;24:591-605.
50. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010;167:748-751.
51. Klein DN, Santiago NJ. Dysthymia and chronic depression: introduction, classification, risk factors, and course. J Clin Psychol 2003;59:807-816.
52. Von Wolff A, Holzel LP, Westphal A, Harter M, Kriston L. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. J Affect Disord 2013;144:7-15.
53. Brown GW, Ban M, Craig TK, Harris TO, Herbert J, Uher R. Serotonin transporter length polymorphism, childhood maltreatment, and chronic depression: a specific gene-environment interaction. Depress Anxiety 2013;30:5-13.
54. Uher R, Caspi A, Houts R, et al. Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. J Affect Disord 2011;135:56-65.
55. Stringaris A, Cohen P, Pine DS, Leibenluft E. Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry 2009;166:1048-1054.
56. Gehlert S, Song IH, Chang CH, Hartlage SA. The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women. Psychol Med 2009;39:129-136.
57. Tschudin S, Bertea PC, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch Womens Ment Health 2010;13:485-494.
58. Landen M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety 2003;17:122-129.
59. Steinberg EM, Cardoso GM, Martinez PE, Rubinow DR, Schmidt PJ. Rapid response to fluoxetine in women with premenstrual dysphoric disorder. Depress Anxiety 2012;29:531-540.
60. Koffel E, Polusny MA, Arbisi PA, Erbes CR. A preliminary investigation of the new and revised symptoms of posttraumatic stress disorder in DSM-5. Depress Anxiety 2012;29:731-738.
61. Elhai JD, Miller ME, Ford JD, Biehn TL, Palmieri PA, Frueh BC. Posttraumatic stress disorder in DSM-5: estimates of prevalence and symptom structure in a nonclinical sample of college students. J Anxiety Disord 2012;26:58-64.
62. Lux V, Aggen SH, Kendler KS. The DSM-IV definition of severity of major depression: inter-relationship and validity. Psychol Med 2010;40:1691-1701.
63. Uher R, Perlis RH, Henigsberg N, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med 2012;42:967-980.
64. Fava M, Hwang I, Rush AJ, Sampson N, Walters EE, Kessler RC. The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010;15:856-867.
65. Judd LL, Schettler PJ, Akiskal H, et al. Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes. J Affect Disord 2012;138:440-448.
66. Perlis RH, Fraguas R, Fava M, et al. Prevalence and clinical correlates of irritability in major depressive disorder: a preliminary report from the Sequenced Treatment Alternatives to Relieve Depression study. J Clin Psychiatry 2005;66:159-166.
67. Fisher HL, Cohen-Woods S, Hosang GM, et al. Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression. J Affect Disord 2012;136:189-193.
68. McGuffin P, Katz R, Watkins S, Rutherford J. A hospital-based twin register of the heritability of DSM-IV unipolar depression. Arch Gen Psychiatry 1996;53:129-136.
69. Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. Am J Psychiatry 2012;169:141-151.
70. Altman DG. Practical Statistics for Medical Researchers. Chapman and Hall, London, England, 1991.
71. Landis JR, Koch GC. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
72. Insel T. Transforming Diagnosis; 2013. Available at: http://www.nimh.nih. gov/about/director/2013/transforming-diagnosis.shtml, Accessed November 17, 2013.
73. Riskind JH, Beck AT, Berchick RJ, Brown G, Steer RA. Reliability of DSM-III diagnoses for major depression and generalized anxiety disorder using the structured clinical interview for DSM-III. Arch Gen Psychiatry 1987;44:817-820.
74. Spitzer RL, Forman JB, Nee J. DSM-III field trials: I. Initial interrater diagnostic reliability. Am J Psychiatry 1979;136:815-817.
75. Williams JB, Gibbon M, First MB, et al. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry 1992;49:630-636.
76. Cheniaux E, Landeira-Fernandez J, Versiani M. The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10. Psychopathology 2009;42:293-298.
77. Keller MB, Klein DN, Hirschfeld RM, et al. Results of the DSM-IV mood disorders field trial. Am J Psychiatry 1995;152:843-849.
78. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 2013;170:59-70.